Find the latest Zomedica Corp. (ZOM) stock quote, history, news and other vital information to help you with your stock trading and investing. Buy. Learn more. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. How has Zomedica's stock been impacted by Coronavirus (COVID-19)? Toggle Search. You can opt out at any time. Zoom Technologies, Inc. () Stock Market info Recommendations: Buy or sell Zoom Technologies stock? Now it trades for more than $480. Even more, the company approximately doubled … There is really no reason to use Zoom if equal or better videoconferencing alternatives exist – especially if the other offerings are less expensive. Zoom has been the videoconferencing service of choice. You may vote once every thirty days. One share of ZOM stock can currently be purchased for approximately C$0.29. Analyzing Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) stock? Learn everything you need to know about successful options trading with this three-part video course. Zomedica Pharmaceuticals Corp. (ZOM.V)'s management team includes the following people: Start Your Risk-Free Trial Subscription Here, Luxury car brand Jaguar to go all-electric by 2025, The Latest: Variants-wary Germany turns back 5,000 at border, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, The Latest: Britain orders quarantine for many travelers, Biden faces questions about commitment to minimum wage hike, Got no milk: Nestle creates vegan KitKat bar, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 3 Oil & Gas Stocks Worth Watching in 2021, U.S. Steel Stock is an Economic Recovery Buy Here, American Axle Manufacturing Stock is an Automotive Recovery and Electrification Play, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Why Zomedica Stock Soared Today and Then Plunged in After-Hours Trading, Tonix, Biolase Join Penny Stocks Surge After Reddit Touts, What Investors Should Know Before Buying Surging Penny Stocks, 3 Top Penny Stocks For Your December 2020 Watch List, 41 Stocks Moving in Wednesday's Pre-Market Session, Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™, Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting, Acerus Pharmaceuticals Co. (ASP.TO) (ASP), Cipher Pharmaceuticals Inc. (CPH.TO) (CPH), Receive Analysts' Upgrades and Downgrades Daily. Since then, ZOM shares have increased by 1,199.3% … In the past three months, Zomedica Pharmaceuticals Corp. (ZOM.V) insiders have not sold or bought any company stock. Zomedica Pharmaceuticals Corp . Zomedica's stock was trading at $0.2078 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Find real-time ZOM - Zomedica Corp stock quotes, company profile, news and forecasts from CNN Business. Some companies that are related to Zomedica Pharmaceuticals Corp. (ZOM.V) include ESSA Pharma Inc. (EPI.V) (EPI), Venture Life Group plc (VLG.L) (VLG), WeedMD Inc. (WMD.V) (WMD), Acerus Pharmaceuticals Co. (ASP.TO) (ASP), Delta 9 Cannabis (NINE), Diurnal Group (DNL), The Flowr (FLWR), BioSyent Inc. (RX.V) (RX), Science in Sport (SIS), Shield Therapeutics plc (STX.L) (STX), InMed Pharmaceuticals Inc. (IN.TO) (IN), Medexus Pharmaceuticals (MDP), Viridium Pacific Group (VIR), Indiva Limited (NDVA.V) (NDVA) and Cipher Pharmaceuticals Inc. (CPH.TO) (CPH). Zomedica Pharmaceuticals Corp. (ZOM.V) has a market capitalization of C$36.73 million. That means Zoom shares are a risky proposition today. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Zomedica Pharmaceuticals Corp. (ZOM.V) has a P/B Ratio of 5.82. That is what we call a “seven-bagger” in this business. The video conferencing expert's stock was more expensive in October and the retreat could very well run even lower from here. Get access to all of the retirement secrets and income strategies from our experts! Learn more. ZOM Stock Price Chart Interactive Chart > ZOM Price/Volume Stats. Zomedica Pharmaceuticals Corp. (ZOM.V) does not currently pay a dividend. Now it trades for more than $480. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Zoom's revenue soared 169% year over year to $328.2 million, crushing an average analyst forecast for revenue of $202.7 million. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Since then, ZM stock has increased by 292.4% and is now trading at $432.77. I don’t see how Zoom’s growth won’t quickly be shut down by deep-pocketed competition. Reason No. Looking for new stock ideas? Welcome! The average equity rating for ZOM stock is currently 2.00, trading closer to a bullish pattern in the stock market. And Zoom’s moat simply doesn’t justify its current valuation. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 1 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. Newsletter FAQs | privacy policy. This is a high-profit-margin business that sees revenue growth actually turn into positive cash flow. Rooms Shows Rankings Earnings Calendar Shop. The company can be reached via phone at 734-369-2555. These companies have seen the waves of people and companies flocking to Zoom, and they want a piece of the action. I think they are going to get it. Zoom’s 2020 revenue growth has been incredible. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Zoom Video Communications Inc - Class A share forecasts, stock quote and buy / sell signals below. volume 288,909,563 : 50-day MA $0.75 : Dividend yield N/A : 200-day MA $0.30 : Market Cap 1.50B : Zomedica Pharmaceuticals Corp. Common Shares (ZOM) Company Bio. If we look at the company’s 10-day average daily trading volume, we find that it stood at 316.55 Million shares traded. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. Click here now. Zomedica Pharmaceuticals Corp. (ZOM.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZOM.". Zoom produces what is widely believed to be the best videoconferencing software on the market. ZOM -- USA Stock : USD 0.17 0.01 6.25% : Zomedica Pharmaceuticals Stock Forecast is based on your current time horizon. Log In. (Add your “underperform” vote.). How will Zoom fare in a price war with Google or Microsoft? NASDAQ 0.00%. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Those terrific results have justifiably driven Zoom’s stock price higher. Learn about financial terms, types of investments, trading strategies and more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Investors can use this forecasting interface to forecast Zomedica Pharmaceuticals historical stock prices and determine the direction of Zomedica Pharmaceuticals Corp's future trends based on various well-known forecasting models. To see all exchange delays and terms of use please see disclaimer. Laying the Foundations for a Stronger Homebuilding Industry. It entered the year at $68. document.getElementById("date").innerHTML = d.getFullYear(); var d = new Date(); Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.5%. Even better, Zoom is not some profitless growth story. HC Wainwright is very positive to ZOM and gave it a "Buy" rating on November 16, 2020. In 2020, businesses across the globe have scrambled to conduct meetings from home. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. MarketBeat's community ratings are surveys of what our community members think about Zomedica Pharmaceuticals Corp. (ZOM.V) and other stocks. View ZOM's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. 1: Zoom’s current valuation is crazy expensive relative to the cash flow that the business generates. According to present data Zoom Video Communications Inc - Class A's ZM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The stock is rated as a Hold by none analyst(s), 1 recommend it as a Buy and no body called the ZOM stock Outperform. Zomedica Pharmaceuticals Corp. (ZOM.V) has received 65.28% “outperform” votes from our community. Want to see which stocks are moving? To judge whether $138 billion is expensive, compare the cash flow and earnings that the business generates. Identify stocks that meet your criteria using seven unique stock screeners. View all of ZOM's competitors. Trading Ideas. The only response that Zoom will have is to lower prices – and that will have an immediate impact on the financial performance of the company, which will in turn hit Zoom’s stock price.
David Burke Cookie Sheet Review, Quik Stats Iowa, Glock 20 Gen 4 Upgrades, Redwood Reserves Promo Code, Long Beach Poly Staff, Deep Personality Test, How Much Does A Bookshelf Weigh, Ecke Poinsettia Ranch,